• Kenneth Offit, MD, MPH

    Chief, Clinical Genetics Service Memorial-Sloan Kettering Cancer Center


    Dr. Kenneth Offit is Chief of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center, a Member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, and a Professor of Medicine and Public Health at the Weill College of Medicine of Cornell University. He is a graduate of Princeton University, the Harvard School of Public Health, and the Harvard Medical School. In 1996, his research group discovered the most common genetic mutation associated with inherited breast and ovarian cancer, occurring among Jews of European ancestry. Dr. Offit's lab also discovered or described recurrent mutations causing increased risk for colon and prostate cancer. In 2002, his group was the first to prospectively measure the impact of preventive ovarian surgery in individuals carrying BRCA mutations. In 2010, his group performed the first genome wide association study of BRCA2 breast cancer and he is currently using next generation sequencing to define genomic markers of risk for leukemia, lymphoma, breast, ovarian, and prostate cancers. Dr. Offit received the 2013 American Cancer Society-American Society of Clinical Oncology Award for his research in cancer prevention, and his text, Clinical Cancer Genetics: Risk Management and Counseling, won an award in Medical Sciences from the Association of American Publishers. He is currently a member of the Board of Scientific Counselors of the U.S. National Cancer Institute, and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.  

     
This website uses cookies to ensure you get the best experience on our website. For more information on the cookies we use, please reference our Privacy Policy.